KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biocryst Pharmaceuticals (BCRX) Interest Coverage Ratio (2016 - 2026)

Biocryst Pharmaceuticals filings provide 15 years of Interest Coverage Ratio readings, the most recent being 18.42 for Q4 2025.

  • On a quarterly basis, Interest Coverage Ratio rose 10090.73% to 18.42 in Q4 2025 year-over-year; TTM through Dec 2025 was 4.32, a 16848.58% increase, with the full-year FY2025 number at 4.32, up 16848.58% from a year prior.
  • Interest Coverage Ratio hit 18.42 in Q4 2025 for Biocryst Pharmaceuticals, up from 1.51 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 18.42 in Q4 2025 to a low of 3.98 in Q1 2021.
  • Median Interest Coverage Ratio over the past 5 years was 0.71 (2022), compared with a mean of 0.0.
  • Biggest five-year swings in Interest Coverage Ratio: rose 0.83% in 2023 and later soared 10090.73% in 2025.
  • Biocryst Pharmaceuticals' Interest Coverage Ratio stood at 2.78 in 2021, then soared by 37.0% to 1.75 in 2022, then rose by 0.83% to 1.74 in 2023, then surged by 89.38% to 0.18 in 2024, then surged by 10090.73% to 18.42 in 2025.
  • The last three reported values for Interest Coverage Ratio were 18.42 (Q4 2025), 1.51 (Q3 2025), and 1.38 (Q2 2025) per Business Quant data.